Literature DB >> 6172383

Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies.

L Pereira, D V Dondero, D Gallo, V Devlin, J D Woodie.   

Abstract

A panel of monoclonal antibodies to herpes simplex virus glycoproteins was used for serological analysis of 130 strains. Based on specific immunological determinants, strains of each serotype clustered into subgroups. Monoclonal antibodies were suitable reagents for serotyping and have potential application to epidemiology of herpes simplex virus infections.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6172383      PMCID： PMC351039          DOI： 10.1128/iai.35.1.363-367.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  SEROLOGICAL COMPARISON OF THE HERPES VIRUSES.

Authors:  G PLUMMER
Journal:  Br J Exp Pathol       Date:  1964-04

2.  Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells.

Authors:  K L Powell; R J Courtney
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

3.  Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites.

Authors:  G S Hayward; N Frenkel; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

4.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

Review 5.  Infection with herpes-simplex viruses 1 and 2. 3.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

6.  Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.

Authors:  K L Powell; A Buchan; C Sim; D H Watson
Journal:  Nature       Date:  1974-05-24       Impact factor: 49.962

7.  A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties.

Authors:  W E Rawls; D Laurel; J L Melnick; J M Glicksman; R H Kaufman
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

8.  Comparison of the virion proteins specified by herpes simplex virus types 1 and 2.

Authors:  E N Cassai; M Sarmiento; P G Spear
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

9.  Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components.

Authors:  G S Hayward; R J Jacob; S C Wadsworth; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

10.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103
View more
  85 in total

1.  Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.

Authors:  G Kümel; H C Kaerner; M Levine; C H Schröder; J C Glorioso
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

2.  Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.

Authors:  S D Marlin; S L Highlander; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.

Authors:  G H Cohen; V J Isola; J Kuhns; P W Berman; R J Eisenberg
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.

Authors:  S Welling-Wester; M Feijlbrief; D G Koedijk; J W Drijfhout; W J Weijer; A J Scheffer; G W Welling
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity.

Authors:  Stephen J Dollery; Catherine C Wright; David C Johnson; Anthony V Nicola
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

6.  Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C.

Authors:  K A Kimmel; K E Dolter; G M Toth; M Levine; J C Glorioso
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  Rapid identification and typing of herpes simplex virus by a new enzyme immunoassay with peroxidase-labeled complement C1q.

Authors:  S M Lee; F Taguchi
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein.

Authors:  K M Zezulak; P G Spear
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2.

Authors:  Francesca Cocchi; Laura Menotti; Valentina Di Ninni; Marc Lopez; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.

Authors:  H P Huemer; Y Wang; P Garred; V Koistinen; S Oppermann
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.